ClinicalTrials.Veeva

Menu

The Level of Blood Brain Barrier Damage Biomarker in Acute Ischemic Stroke

J

Ji Xunming,MD,PhD

Status

Enrolling

Conditions

Ischemic Stroke

Treatments

Diagnostic Test: the level of biomarker in bood

Study type

Observational

Funder types

Other

Identifiers

NCT05321225
BBBD-AIS

Details and patient eligibility

About

Hemorrhagic transformation is a common complication of acute ischemic stroke patients . BBB damage is regarded as a major pathophysiological mechanism of hemorrhagic transformation. So, the investigators hypothesis the level of BBB damage biomarker is predictor of intracranial hemorrhage following ischemic stroke.

Full description

Hemorrhagic transformation is a common complication of acute ischemic stroke patients . BBB injury often occurs in the early stage of ischemic stroke, leading brain tissue edema or even hemorrhagic transformation with the development of ischemic injury. The biomarker of BBB damage, such as the level of serum occludin, can reflect the extent of BBB injury. So, the investigators hypothesis the level of BBB damage biomarker is predictor of intracranial hemorrhage following ischemic stroke.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Enrolled patients aged 18-80years.
  2. Acute ischemic stroke
  3. Informed consent obtained.

Exclusion criteria

  1. Tumor stroke or hemorrhagic stroke or hemorrhagic cerebral infarction on admission.
  2. Stroke or serious head trauma within the previous 3 months
  3. inflammatory or infectious diseases, cancer, coagulation disturbance disease and severe renal and liver failure
  4. blood sample occurred hemolysis or cloudy.
  5. Incomplete clinical data
  6. Platelet count of less than 100,000 per cubic millimeter
  7. Received oral anticoagulation therapy preceding the onset of stroke and INR greater than 1.7 or prothrombin times greater than 15 seconds
  8. Pregnant or breast-feeding women
  9. Patients being enrolled or having been enrolled in other clinical trial -

Trial contacts and locations

1

Loading...

Central trial contact

Zhifeng Qi, PhD; xunming ji, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems